The Nordic Society of Human Genetics and Precision Medicine (NSHG-PM) was created in order to: 
  • establish a Nordic framework for research into the genetics of human diseases, as well as into human evolution and population history;
  • accelerate discovery of disease susceptibility genes and genes protecting from disease through integrated analyses using multiple large-scale datasets and a range of experimental designs;
  • translate these findings so that they can be used for precision medicine to improve public health;
  • and uphold and promote the highest legal, regulatory, social, and ethical standards.   

We will do this by working with pertinent experts and other stakeholders at local, national and regional levels.

Our Nordic Society consist of members from Denmark, Estonia, Finland, Iceland, Norway and Sweden. 

Find out more about NSHG-PM here

You can also sign up to our newsletters to receive the latest news from the Nordic Society of Human Genetics and Precision Medicine.

Executive Committee


  • Ole Andreassen, University of Oslo (President)
  • Ingrid Kockum, Karolinska Institutet, Sweden (Vice-President)
  • Søren Brunak, University of Copenhagen, Denmark (Treasurer)
  • Bo Jacobsson, University of Gothenburg, Sweden
  • Andres Metspalu, University of Tartu, Estonia
  • Lili Milani, University of Tartu, Estonia
  • Pål Njølstad, University of Bergen, Norway
  • Aarno Palotie, Institute for Molecular Medicine Finland
  • Samuli Ripatti, Institute for Molecular Medicine Finland
  • Hreinn Stefánsson, deCODE Genetics, Iceland
  • Kári Stefánsson, deCODE Genetics and University of Iceland
  • Thomas Werge, Mental Health Centre Sct. Hans, Denmark
  • Hakon Heimer, University of Copenhagen, Denmark (executive official)